Some of the big questions we try to teach in Epidemiology for Lawyers, whether students go to a firm, the Hill, WH, judiciary or elsewhere: what principles & processes help us make decisions on limited data & how do we change decisions (but keep trust) as evidence evolves?
Two quick examples:

for the first question,
1) what is the quality of the evidence (systematic review, cohort, case study)
2) is better evidence possible
3) could it do harm to wait or act (e.g. should we apply a precautionary approach)
for the second question, using clear risk communication strategies early on can help minimize damage to public trust. Tell public:
1. what we know (how we know)
2. what we don't know
3. what we're doing to find out more
4. when we'll give our next update
These are just snippets and not comprehensively, but building scientific literacy for policy-makers and for the public, is critical.

Prior to 2020, I wanted to rename the course "scientific literacy for lawyers", but now everyone knows what an epidemiologist is.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr Alexandra Phelan

Dr Alexandra Phelan Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @alexandraphelan

20 Feb
Unofficial reports so far state that the subtype is H5N8 – this would be a novel influenza subtype in humans.

The IHR require immediate reporting of *any* novel human influenza subtypes as potential PHEICs, no matter how serious.
Since 2020, there has been a global H5N8 outbreak among bird populations – wild birds and poultry. Cases have been reported in Saudi Arabia, Russia, Kazakhstan, Netherlands, Germany, Denmark, UK, France, Sweden, India, Japan, Norway, South Korea.

e.g. Estonia's 17 Feb OIE report
We may have just seen the leap occur from animals to humans here because of the nature of the human/animal interactions in this poultry farm, or there may be something genetically distinct. We need sequencing to know this.
Read 6 tweets
20 Feb
Russian has reported seven human cases of avian influenza to @WHO

No confirmation of subtype yet.

No evidence yet of human to human transmission: all cases reported are workers in a poultry plant.

reuters.com/article/us-hea…
There have been a few highly pathogenic avian influenza infections (HPAI) across Europe recently in wild birds (@OIEAnimalHealth – WAHIS appears to be down this morning?)
Under the International Health Regulations (2005), countries must report any cases of a novel influenza subtype in humans as a potential PHEIC.

This is the first cluster in humans of an HPAI in Europe reported this year. It is not yet up on WHO DONs or promed.
Read 9 tweets
29 Jan
*Public health actions to control new SARS-CoV-2 variants*

Our paper just published in @CellCellPress w wonderful co-authors @NathanGrubaugh @firefoxx66 @JosephFauver & @mugecevik

We describe actions govts should urgently take to protect health.

🧵1/7

cell.com/cell/fulltext/…
New SARS-CoV-2 variants of concern will continue to emerge: exacerbating already crippling outbreaks & potentially reducing efficacy of some vaccines, cause increased rates of reinfections and prolonging the pandemic.

2/7
As SARS-Cov-2 variants of concern to date have shown: these are global issues. There must be urgent multilateral cooperation between countries to:
– build local sequencing capacities
– rapidly share sequence data globally
*and separately*

3/7
Read 7 tweets
29 Jan
Today, @ThinkGlobalHlth is celebrating its one year anniversary. @RebeccaKatz5 & I were fortunate enough to be invited to write a piece for this new @CFR_org blog, led by @TomBollyky.

Some reflections from that piece on why global governance matters.
thinkglobalhealth.org/article/why-gl…
From the outset, it was obvious that global governance was about to be seriously tested. Unfortunately, over this pandemic we've seen that play out to be the case – not only globally but also national governance.
There was a huge risk that WHO would be sidelined because states rejected WHO advice (for a range of reasons), but also because it has been woefully underfunded for years.
Read 6 tweets
22 Dec 20
I disagree with folks dismissing the implications of the UK variant of concern.

While individual behaviors to avoid transmission may not change, the impact at the population level is serious: hospitals are already at capacity.

Quick thread
/1
Any factor that ramps up transmission (biological or behavioral) amplifies cases, and as a result, severe cases and deaths. When hospitals hit capacity, cases that could have been treated successfully will be triaged along increasingly stringent crisis standards of care.
/2
At the population level, this also impacts government responses about control measures, which impacts now & future justifications
Short thread on that here:
/3

Read 6 tweets
21 Dec 20
Public Health England has just released their updated report on the UK #SARSCoV2 variant

"Investigation of novel SARS-CoV-2 variant: Variant of Concern 202012/01"

I'll do a quick summary thread below & link to report:
A cluster was identified & used to assess increasing incidence of the Variant of Concern (designated as such 18 Dec) in Kent, UK:
- 4% (255/6130) of Kent cases had available genomes
- in Kent: 117 genomically similar cases identified (10-19 Nov)
- in UK: 962 genomes of VoC(8 Dec)
Out of that 962 UK wide, epi data was available for 915 individuals.

As of 20 Dec, VoC present mainly in London, South East & East of England regions.

The report goes into the details of how the VoC testing is carried out.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!